Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01878383 · ClinicalTrials.gov registry record

Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture

A clinical trial, sponsored by University of Alabama at Birmingham.

Completed
Registry status
12,550
Enrollment target

NCT01878383 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 12,550 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01878383 has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
12,550 participants
Enrollment target

Study Summary

PCR detection of HSV DNA shedding in the female genital tract using the GeneXpert system (Cepheid, Sunnyvale CA) will be compared with traditional (routine) PCR (pregnant and nonpregnant women) and with HSV culture (nonpregnant women). The GeneXpert system performs all sample-processing steps and real-time PCR in a single integrated cartridge. The standard cartridge is an inexpensive disposable plastic cartridge with filtration and ultrasonic lysis capabilities. It consists chiefly of several combined molded plastic components: a cartridge body containing eleven fluid reservoirs or chambers along with an attached PCR tube, a specialized valve body with an ultrasonic interface containing a sub-micron filter and glass lysis beads, and a rotary valve with an axial syringe barrel. The operation of the cartridge is simple. The rotary valve contains an inlet and an outlet port. Fluid such as a sample buffer can be drawn up into a syringe drive through the inlet port of the rotary valve and then dispensed into any other chamber within the cartridge by rotating the valve and expelling the fluid through the outlet port. The fluid can either be passed through a filter contained within the valve assembly or it can be passed directly into the next chamber without filtration, depending on the path that is chosen. The cartridge fluidics and subsequent real-time PCR all are performed within the GeneXpert instrument. The GeneXpert contains multiple modules (ICORE units) that can be independently programmed to drive the syringe/rotary valve, and to perform four-color real-time PCR. Each cartridge fits inside one module, and all processing, PCR, and analysis steps are performed automatically. Each ICORE module can be run and analyzed independently, so batching of samples is unnecessary.

Interventions

  • DEVICE Genexpert assay

Trial Details

FieldValue
Enrollment Target 12,550 participants
Start Date 2014-01
Est. Completion 2019-12-31

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT01878383

The ClinicalTrials.gov registry entry for NCT01878383 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12,550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Genexpert assay is the first listed.

NCT01878383 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01878383 about?

NCT01878383 is a clinical study titled "Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture". PCR detection of HSV DNA shedding in the female genital tract using the GeneXpert system (Cepheid, Sunnyvale CA) will be compared with traditional (routine) PCR (pregnant and nonpregnant women) and with HSV culture (nonpregnant women). The GeneXpert system performs all sample-processing steps and re...

What is the current status of trial NCT01878383?

This trial is currently completed. The enrollment target is 12,550 participants. The study started on 2014-01. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT01878383?

The interventions under investigation include: Genexpert assay (DEVICE).

Who is sponsoring clinical trial NCT01878383?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.